HomeAI · summaries
Storia in 2 fonti
How one biotech is using 'digital twins' to study a muscle disease therapy
Epicrispr reports early cut data showing lean muscle gains on its FSHD epigenetic editing therapy EPI-321, using AI
Confronto fonti
2 prospettive sulla stessa storiaTimeline cronologica
- ·
endpoints.news
How one biotech is using 'digital twins' to study a muscle disease therapy
Epicrispr reports early cut data showing lean muscle gains on its FSHD epigenetic editing therapy EPI-321, using AI
- ·
morningstar.com
Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321
Epicrispr Reports First Clinical Evidence of Increased Lean Muscle Volume in Patients with FSHD Following Treatment with EPI-321